--- title: "Alpenglow Biosciences Introduces Summit AI for Quantitative Analysis of Whole Tissue Imaging in Dermatology" type: "News" locale: "en" url: "https://longbridge.com/en/news/285236292.md" description: "Alpenglow Biosciences has launched Summit AI, a multimodal AI platform for quantitative analysis of whole tissue imaging in dermatology. This platform converts complex imaging data into structured spatial readouts while maintaining the original image context. Initially focused on inflammatory skin diseases, Summit AI aims to enhance tissue analysis by providing comprehensive insights into tissue architecture and disease states. It integrates 3D imaging with 2D readouts and includes uncertainty metrics to improve confidence in model outputs, supporting drug development and clinical diagnostics." datetime: "2026-05-05T15:43:20.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285236292.md) - [en](https://longbridge.com/en/news/285236292.md) - [zh-HK](https://longbridge.com/zh-HK/news/285236292.md) --- # Alpenglow Biosciences Introduces Summit AI for Quantitative Analysis of Whole Tissue Imaging in Dermatology A new multimodal AI platform called Summit AI has been launched by Alpenglow Biosciences in Seattle. This platform is designed to convert 3D tissue imaging into quantitative spatial data to support dermatology research and development. Summit AI aims to enhance the accuracy and efficiency of analyzing tissue samples for research purposes, catering to the increasing demand for advanced technology in this field. This innovation is set to revolutionize the way dermatology R&D is conducted, offering a more comprehensive and precise approach to studying tissue samples. ### Related Stocks - [ALLO.US](https://longbridge.com/en/quote/ALLO.US.md) - [MBX.US](https://longbridge.com/en/quote/MBX.US.md) - [DTIL.US](https://longbridge.com/en/quote/DTIL.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) ## Related News & Research - [Incyte expands Genesis Molecular AI collaboration, pays USD 120 million upfront](https://longbridge.com/en/news/287060301.md) - [BMY Stock Rises as Bristol Myers Brings Anthropic's Claude AI to 30,000 Employees](https://longbridge.com/en/news/287076466.md) - [Lantern Pharma raises capital, plans AI platform spinoff](https://longbridge.com/en/news/286480334.md) - [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md) - [Skye Bioscience opens higher-dose Cohort 2 in nimacimab obesity Phase 2a study](https://longbridge.com/en/news/287053007.md)